Pfizer CEO Bourla on Acuitas Deal, mRNA Tech, Djokovic

Pfizer Chairman and CEO Albert Bourla discusses the partnership with Acuitas Therapeutics, vaccine development, and tennis star Novak Djokovic’s Australian visa reinstatement. He speaks on “Bloomberg Surveillance.“